DEPROMP Trial: the additive value of PSMA-PET/CT-guided biopsy for prostate cancer management in biopsy naïve men—study protocol for a randomized trial

BACKGROUND: The primary objective is to determine the proportion of men with suspected prostate cancer (PCA) in whom the management plans are changed by additive gallium-68 prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA-PET/CT) guided prostate biopsy (PET-T...

Descripción completa

Detalles Bibliográficos
Autores principales: Krausewitz, P., Bundschuh, R. A., Gaertner, F. C., Essler, M., Attenberger, U., Luetkens, J., Kristiansen, G., Muders, M., Ohlmann, C-H., Hauser, S., Ellinger, J., Ritter, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987083/
https://www.ncbi.nlm.nih.gov/pubmed/36879271
http://dx.doi.org/10.1186/s13063-023-07197-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987083/
https://www.ncbi.nlm.nih.gov/pubmed/36879271
http://dx.doi.org/10.1186/s13063-023-07197-0

Ejemplares similares